本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ascendis Pharma A/S

263.52
+2.290.87%
盤後263.520.00000.00%19:52 EDT
成交量:44.36萬
成交額:1.17億
市值:174.42億
市盈率:20.33
高:266.34
開:263.34
低:259.48
收:261.23
52周最高:282.15
52周最低:186.05
股本:6,618.99萬
流通股本:6,553.95萬
量比:0.65
換手率:0.68%
股息:- -
股息率:- -
每股收益(TTM):12.96
每股收益(LYR):-4.4176
淨資產收益率:118.78%
總資產收益率:9.58%
市淨率:10.50
市盈率(LYR):-59.65

資料載入中...

2019/05/01

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/19

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/03

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/12

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/03/08

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/01

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/15

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/12

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/02/11

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/08

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/11

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/01/10

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]